Urogen pharma to present at the td cowen 5th annual oncology innovation summit

Princeton, n.j.--(business wire)--urogen pharma ltd. (nasdaq: urgn), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that management will participate in a virtual fireside chat at the td cowen 5th annual oncology innovation summit on tuesday, may 28, 2024 at 3:20 pm et. a live webcast of the fireside chat can be accessed by visiting the events and presentations section of the company's website: https.
COWN Ratings Summary
COWN Quant Ranking